glioblastoma

December 21, 2025 | Beijing, China — T-MAXIMUM Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has...

NEW YORK, November 6, 2025 — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing gamma-delta (γδ) T cell...

BRONX, NY, Oct. 3, 2025 — Researchers at Montefiore Einstein and Albert Einstein College of Medicine reveal that glioblastoma...